Le Lézard
Classified in: Health, Science and technology

Genomenon Awarded NIH NHGRI Grant to Curate the Human Genome

ANN ARBOR, Mich., Feb. 15, 2022 /PRNewswire-PRWeb/ -- Genomenon, Inc., an AI-driven genomics company, today announced that it was awarded a $1.7 million grant by the National Institutes of Health (NIH) through the Small Business Innovation Research (SBIR) program. The grant is to accelerate development of the Mastermind® Genomic Search Engine, the company's AI-driven variant interpretation engine, with a vision of curating the entire human genome. The grant enables Genomenon to increase the expertly curated evidence needed for clinicians to make a genetic diagnosis, extending Mastermind beyond its current function as the most complete source of genomic information for medical research.

The NIH's SBIR program focuses on a variety of high-impact technologies spanning research tools, diagnostics, digital health, drugs, and medical devices. It provides funding needed to bring scientific innovations from bench to bedside. Awarded by the NIH's National Human Genome Research Institute, this grant will fund the continued evolution of Genomenon's AI-driven genomic engine, as well as the incorporation of collaborative features for community-based variant interpretation¹.

"Having already curated more than 250 genes for rare diseases and cancer, this NIH funding allows us to accelerate the pace of genetic interpretation for our AI-driven curation engine, which is a crucial first step in a process that enables targeted and efficient use of expert human curators," said Mike Klein, CEO of Genomenon. "Next-generation sequencing gives us the ability to quickly and efficiently create a large amount of genomic data. Curating the entire genome for meaning and actionability at scale is the next step in the evolution of using this information to improve patient care."

Mastermind is the world's most comprehensive source for genomic literature in the variant interpretation space. Used by more than 1,000 diagnostic labs and integrated into 18 clinical-grade decision support platforms and reference databases across the globe, Mastermind connects patient genetic data with critical evidence from scientific literature needed to diagnose rare genetic diseases and cancer.

About Genomenon

Genomenon is an AI-driven genomics company that organizes the world's genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer.

For more information, visit Genomenon.com

1. Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R43HG010446. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Media Contact

Candace Chapman, Genomenon, 1-734-219-5175, [email protected]


SOURCE Genomenon

These press releases may also interest you

at 03:30
According to Technavio, the global deep learning market size is projected to grow by USD 11113.13 million from 2022 to 2027. The market is estimated to grow at a CAGR of 29.79% during the forecast period. North America held the largest share of the...

at 03:00
The digital content market size is forecasted to increase by USD 694.88 billion from 2022 to 2027, at a CAGR of 13.78%, according to a recent market study by Technavio. The growth of the market will be driven by digital transformation across sectors,...

at 02:30
Gaming Innovation Group (GiG) has entered into a new commercial partnership with News Corp UK & Ireland Limited. News UK serves millions of online readers through its premium media websites, The Sun and talkSPORT. GiG and News UK will join forces to...

at 02:15
Kapsch TrafficCom is proud to announce that it successfully delivered the very first barrier-free tolling system in France, for which it supplied the road side equipment and the transaction collection system. Since November 4, drivers no longer have...

at 02:04
Since its creation in 2000, Datawords Group has established itself as a leader in e-multicultural technologies, forging the term Multicultural Ingenuitytm [1] to reflect its capacity to support brands in the deployment of their digital marketing and...

at 02:00
Deep Isolation announced today it is part of a grant project awarded to EPRI, Oak Ridge National Laboratory (ORNL) and Southern Company Research and Development. The $2.8 million grant from the U.S. Department of Energy (DOE) is for a joint nuclear...

News published on 15 february 2022 at 00:00 and distributed by: